Publicaties
Filter de resultaten op :
Publicatie categorie 12
Microscopic Disease Extension in Three Dimensions for Non-Small-Cell Lung Cancer: Development of a Prediction Model Using Pathology-Validated Positron Emission Tomography and Computed Tomography Features.
2010
Int J Radiat Oncol Biol Phys. 2010 Oct 23.
van Loon J, Siedschlag C, Stroom J, Blauwgeers H, van Suylen RJ, Knegjens J, Rossi M, van Baardwijk A, Boersma L, Klomp H, Vogel W, Burgers S, Gilhuijs K.
4,592
Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.
2010
J Clin Oncol. 2010 Mar 10;28(8):1380-6.
van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Lambin P, De Ruysscher D.
17,793
Effectiveness of surgery and individualized high-dose hyperfractionated accelerated radiotherapy on survival in clinical stage I non-small cell lung cancer. A propensity score matched analysis
2010
Radiotherapy and Oncology, Volume 97, Issue 3, December 2010, Pages 413-417
Marcelo F. Jimenez, Angela van Baardwijk, Hugo J.W.L. Aerts, Dirk De Ruysscher, Nuria M. Novoa, Gonzalo Varela, Philippe Lambin
4,343
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
2010
Radiotherapy & Oncology Volume 96, Issue 2 , Pages 145-152, August 2010
Philippe Lambin, Steven F. Petit, Hugo J.W.L. Aerts, Wouter J.C. van Elmpt, Cary J.G. Oberije, Maud H.W. Starmans, Ruud G.P.M. van Stiphout, Guus A.M.S. van Dongen, Kristoff Muylle, Patrick Flamen, Andr� L.A.J. Dekker, Dirk De Ruysscher
4,343
FDG for dose painting: a rational choice.
2010
Radiother Oncol. 2010 Nov;97(2):163-4. Epub 2010 Jun 17.
Aerts HJ, Lambin P, Ruysscher DD.
4,343
Primary Ewing's sarcoma presenting as a Pancoast tumour.
2010
Radiother Oncol. 2010 Nov;97(2):163-4. Epub 2010 Jun 17. No abstract available. PMID: 20561697 [PubMed - in process]Related citations
Vanfleteren L, van Stiphout R, Riedl RG, Jansen R, De Ruysscher D, Dingemans AM.
4,343
European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.
2010
J Clin Oncol. 2010 Dec 20;28(36):5301-10. Epub 2010 Nov 15.PMID: 21079134 [PubMed - in process]Related citations
De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le P�choux C, Price A, Senan S.
17,793
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
2010
Eur Radiol. 2010 Dec;20(12):2890-8. Epub 2010 Jul 13.
Lind JS, Meijerink MR, Dingemans AM, van Kuijk C, Ollers MC, de Ruysscher D, Postmus PE, Smit EF
3,589
Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients.
2010
Radiother Oncol. 2010 Dec;97(3):455-61.PMID: 21084125 [PubMed - in process]
Dehing-Oberije C, De Ruysscher D, Petit S, Van Meerbeeck J, Vandecasteele K, De Neve W, Dingemans AM, El Naqa I, Deasy J, Bradley J, Huang E, Lambin P.
4,343
18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation.
2010
Eur J Cancer 46 (1):110-119, 2010.
van Loon J, Grutters JPC, Wanders R, Boersma L, Dingemans AC, Bootsma G, Geraedts W, Pitz C, Simons J, Brans B, Snoep G, Hochstenbag M, Lambin P, De Ruysscher D
4,121
Health-related quality of life in patients surviving non-small cell lung cancer.
2010
Thorax. 2010 Oct;65(10):903-7.
Grutters JP, Joore MA, Wiegman EM, Langendijk JA, de Ruysscher D, Hochstenbag M, Botterweck A, Lambin P, Pijls-Johannesma M.
7,041
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
2010
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):329-36.
van Loon J, De Ruysscher D, Wanders R, Boersma L, Simons J, Oellers M, Dingemans AM, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Teule J, Rhami A, Thimister W, Snoep G, Dehing-Oberije C, Lambin P.
4,592
ESMO Guidelines Working Group. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
2010
Ann Oncol. 2010 May;21 Suppl 5:v120-5
S�rensen M, Pijls-Johannesma M, Felip E
5,647
Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer.
2010
Radiother Oncol. 2010 May;95(2):203-8.
Janssen MH, Ollers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G.
4,343
Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findings.
2010
Radiother Oncol. 2010 Feb;94(2):156-60.
Janssen MH, Aerts HJ, Kierkels RG, Backes WH, Ollers MC, Buijsen J, Lambin P, Lammering G.
4,343
Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
2010
. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):400-8.
Kierkels RG, Backes WH, Janssen MH, Buijsen J, Beets-Tan RG, Lambin P, Lammering G, Oellers MC, Aerts HJ
4,592
Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging.
2010
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):392-9.
Janssen MH, Ollers MC, Riedl RG, van den Bogaard J, Buijsen J, van Stiphout RG, Aerts HJ, Lambin P, Lammering G.
4,592
Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings.
2010
Radiother Oncol. 2010 Feb;94(2):151-5.
Janssen MH, Ollers MC, van Stiphout RG, Buijsen J, van den Bogaard J, de Ruysscher D, Lambin P, Lammering G.
4,343
Information needs of early-stage prostate cancer patients: a comparison of nine countries.
2010
Radiother Oncol. 2010 Mar;94(3):328-33
Feldman-Stewart D, Capirci C, Brennenstuhl S, Tong C, Abacioglu U, Gawkowska-Suwinska M, van Gils F, Heyda A, Igdem S, Macias V, Grillo IM, Moynihan C, Pijls-Johannesma M, Parker C, Pimentel N, W�rdehoff H.
4,343
Dummy run and conformity indices in the ongoing EORTC Low Grade Glioma Trial 22033-26033: first evaluation of quality of radiotherapy planning
2010
Radiother Oncol. 2010 May;95(2):218-24
Musat E, Roelofs E, Bar-Deroma R, Fenton P, Gulyban A, Collette L, Stupp R, Weber DC, Davis JB, Aird E, Baumert BG
4,343